Rocuronium Bromide Injection
Product Images NDC 43066-007
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 43066-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Rocuronium Function of Dose)
Figure 2 (Rocuronium Function of Dose)
Figure 3 (Rocuronium Clinical Durations)
Rocuronium Representative Container Label 43066-007-10 (Image 05)
Rocuronium Representative Carton Label 43066-007-10 1 Of 2 (Image 06)
Rocuronium Representative Carton Label 43066-007-10 2 Of 2 (Image 07)
Rocuronium Representative Container Label 43066-013-10 (Image 08)
Rocuronium Representative Carton Label 43066-013-10 1 Of 2 (Image 09)
Rocuronium Representative Carton Label 43066-013-10 2 Of 2 (Image 10)
Image 11
Image 12
Image 13
This is a medication called Rocuronium Bromide, which comes in the form of vials that contain 100mg of the active ingredient in 10mL of liquid (10mg/mL). It is administered through intravenous use only. However, it is essential to note the WARNING label that this medication is a paralyzing agent, and therefore, it should only be used by authorized healthcare professionals. The manufacturer is R oniy Baxter.*
Image 14
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.